Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program

Journal of Substance Abuse Treatment

Volumn 36, Issue 3, 2009, Pages 306-312

  Havens, Jennifer R ^a   Latkin, Carl A ^b   Pu, Minya ^c   Cornelius, Llewellyn J ^d   Bishai, David ^b   Huettner, Steve ^e   Rapp, Charles ^f   Ricketts, Erin P ^b   Lloyd, Jacqueline J ^g   Strathdee, Steffanie A ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KANSAS   (United States)

^g TEMPLE UNIVERSITY   (United States)

Author keywords

Injection drug use; Needle exchange; Opioid agonist therapy; Strengths based case management; Treatment retention

Indexed keywords

OPIATE AGONIST;

ADULT; ARTICLE; CASE MANAGEMENT; CONTROLLED STUDY; DISTRESS SYNDROME; DRUG DEPENDENCE TREATMENT; EMPLOYMENT STATUS; ENVIRONMENTAL FACTOR; FEMALE; HEALTH CARE AVAILABILITY; HEALTH PROGRAM; HOUSING; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MOTIVATION; OPIATE ADDICTION; PATIENT COMPLIANCE; PATIENT REFERRAL; PRIORITY JOURNAL; SOCIAL ASPECT; SUBSTANCE ABUSE; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES;

ADULT; AIDS SERODIAGNOSIS; ANALGESICS, OPIOID; BALTIMORE; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; NEEDLE-EXCHANGE PROGRAMS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 61349169065     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2008.07.002     Document Type: Article

References (50)

1. Babor T.F., de la Fuente J.R., Saunders J.B., and Grant M. AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for use in primary health care (1989) Geneve, Switzerland
2. Bastos F.I., and Strathdee S.A. Evaluating effectiveness of syringe exchange programmes: Current issues and future prospects. Social Science Medicine 51 (2000) 1771-1782
3. Bishai D., Sindelar J., Ricketts E.P., Huettner S., Cornelius L., Lloyd J.J., et al. Willingness to pay for drug rehabilitation: Implications for cost recovery. Journal Health Economics 27 (2007) 959-972
4. Booth R.E., Corsi K.F., and Mikulich S.K. Improving entry to methadone maintenance among out-of-treatment injection drug users. Journal of Substance Abuse Treatment 24 (2003) 305-311
5. Booth R.E., Corsi K.F., and Mikulich-Gilbertson S.K. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug and Alcohol Dependence 74 (2004) 177-185
6. Brooner R., Kidorf M., King V., Beilenson P., Svikis D., and Vlahov D. Drug abuse treatment success among needle exchange participants. Public Health Report 113 Suppl 1 (1998) 129-139
7. Carroll K.M., Power M.E., Bryant K., and Rounsaville B.J. One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. Journal of Nervous and Mental Disease 181 (1993) 71-79
8. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR Morbidity and Mortality Weekly Report 50 (1999) 1-58
9. Cornelius L.J., LLoyd J.J., Bishai D., Latkin C., Huettner S., Brown M., et al. The treatment retention intervention: A case study of an evaluation of a case management intervention to improve treatment outcomes for injection drug users. Journal of the Association for Academic Minority Physicians 17 (2006) 44-53
10. Cox D.R., and Snell E.J. A general definition of residuals (with discussion). Journal of the Royal Statistical Society B30 (1968) 248-275
11. Darke S., Ross J., Teesson M., Ali R., Cooke R., Ritter A., et al. Factors associated with 12 months continuous heroin abstinence: Findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment 28 (2005) 255-263
12. Esteban J., Gimeno C., Barril J., Aragones A., Climent J.M., and de la Cruz P.M. Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment. Drug Alcohol Dependence 70 (2003) 193-200
13. Flynn P.M., Joe G.W., Broome K.M., Simpson D.D., and Brown B.S. Recovery from opioid addiction in DATOS. Journal of Substance Abuse Treatment 25 (2003) 177-186
14. Friedmann P.D., D'Aunno T.A., Jin L., and Alexander J.A. Medical and psychosocial services in drug abuse treatment: Do stronger linkages promote client utilization?. Health Services Research 35 (2000) 443-465
15. Friedmann P.D., Lemon S.C., and Stein M.D. Transportation and retention in outpatient drug abuse treatment programs. Journal of Substance Abuse Treatment 21 (2001) 97-103
16. German D., Davey M.A., and Latkin C.A. Residential transience and HIV risk behaviors among injection drug users. AIDS and Behavior 11 (2007) 21-30
17. Gossop M., Marsden J., Stewart D., and Treacy S. Reduced injection risk and sexual risk behaviours after drug misuse treatment: Results from the National Treatment Outcome Research Study. AIDS Care 14 (2002) 77-93
18. Green L.W., Richard L., and Potvin L. Ecological foundations of health promotion. American Journal of Health Promotion 10 (1996) 270-281
19. Hagan H., McGough J.P., Thiede H., Hopkins S., Duchin J., and Alexander E.R. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment 19 (2000) 247-252
20. Haverkos H.W. HIV/AIDS and drug abuse: Epidemiology and prevention. Journal of Addictive Diseases 17 (1998) 91-103
21. Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment?. Journal of Substance Abuse Treatment 15 (1998) 183-191
22. Henderson L.A., Vlahov D., Celentano D.D., and Strathdee S.A. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. Journal Acquired Immune Deficiency Syndromes 32 (2003) 229-237
23. Hser Y.I., Anglin M.D., Grella C., Longshore D., and Prendergast M.L. Drug treatment careers. A conceptual framework and existing research findings. Journal of Substance Abuse Treatment 14 (1997) 543-558
24. Joe G.W., Simpson D.D., and Broome K.M. Retention and patient engagement models for different treatment modalities in DATOS. Drug Alcohol Dependence 57 (1999) 113-125
25. Kwiatkowski C.F., Booth R.E., and Lloyd L.V. The effects of offering free treatment to street-recruited opioid injectors. Addiction 95 (2000) 697-704
26. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., et al. The Fifth Edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 9 (1992) 199-213
27. Metzger, D. S. & Navaline, H. (2003). Human immunodeficiency virus prevention and the potential of drug abuse treatment. Clinival Infectious Diseases, 37, Suppl 5:S451-6., S451-S456.
28. Metzger D.S., Navaline H., and Woody G.E. Drug abuse treatment as AIDS prevention. Public Health Report 113 Suppl 1 (1998) 97-106
29. Metzger D.S., Woody G.E., McLellan A.T., O'Brien C.P., Druley P., Navaline H., et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 6 (1993) 1049-1056
30. Pani P.P., Trogu E., Contu P., Agus A., and Gessa G.L. Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug Alcohol Dependence 48 (1997) 119-126
31. Preston K.L., Umbricht A., and Epstein D.H. Abstinence reinforcement maintenance contingency and one-year follow-up. Drug Alcohol Dependence 67 (2002) 125-137
32. Radloff L.S. The CES-D scale: A self report depression scale for research in the general population. Applied Psychological Measurement 1 (1977) 385-401
33. Rapp C.A., and Chamberlain R. Case management services to the chronically mentally ill. Social Work 30 (1985) 417-422
34. Rapp R.C., Siegal H.A., and Fisher J.H. A strengths-based model of case management/advocacy: Adapting a mental health model to practice work with persons who have substance abuse problems. NIDA Research Monograph 127 (1992) 79-91
35. Rapp R.C., Siegal H.A., Li L., and Saha P. Predicting postprimary treatment services and drug use outcome: A multivariate analysis. American Journal Drug Alcohol Abuse 24 (1998) 603-615
36. Royse D., Leukefeld C., Logan T.K., Dennis M., Wechsberg W., Hoffman J., et al. Homelessness and gender in out-of-treatment drug users. American Journal Drug Alcohol Abuse 26 (2000) 283-296
37. Schoenfeld D. Chi-squared goodness-of-fit tests for the proportional hazards regression model. Biometrika 67 (1980) 145-153
38. Schwartz R.P., Jaffe J.H., Highfield D.A., Callaman J.M., and O'Grady K.E. A randomized controlled trial of interim methadone maintenance: 10-Month follow-up. Drug Alcohol Dependence 86 (2007) 30-36
39. Shah N.G., Celentano D.D., Vlahov D., Stambolis V., Johnson L., Nelson K.E., et al. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 14 (2000) 2035-2043
40. Shah N.G., Galai N., Celentano D.D., Vlahov D., and Strathdee S.A. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug Alcohol Dependence 83 (2006) 147-156
41. Siegal H.A., Fisher J.H., Rapp R.C., Kelliher C.W., Wagner J.H., O'Brien W.F., et al. Enhancing substance abuse treatment with case management. Its impact on employment. Journal of Substance Abuse Treatment 13 (1996) 93-98
42. Siegal H.A., Li L., and Rapp R.C. Case management as a therapeutic enhancement: Impact on post-treatment criminality. Journal of Addictive Disease 21 (2002) 37-46
43. Simpson D., Joe G.W., and Brown B.S. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behavior 11 (1997) 294-307
44. Sorensen J.L., and Copeland A.L. Drug abuse treatment as an HIV prevention strategy: A review. Drug Alcohol Dependence 59 (2000) 17-31
45. Strathdee S.A., Celentano D.D., Shah N., Lyles C., Stambolis V.A., Macalino G., et al. Needle-exchange attendance and health care utilization promote entry into detoxification. Journal Urban Health 76 (1999) 448-460
46. Strathdee S.A., Ricketts E.P., Huettner S., Cornelius L., Bishai D., Havens J.R., et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug Alcohol Dependence 83 (2006) 225-232
47. Teesson M., Mills K., Ross J., Darke S., Williamson A., and Havard A. The impact of treatment on 3 years' outcome for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Addiction 103 (2008) 80-88
48. Tuten M., and Jones H.E. A partner's drug-using status impacts women's drug treatment outcome. Drug Alcohol Depend. 70 (2003) 327-330
49. UNAIDS. Urgent action needed to improve access to HIV prevention and treatment services for people who inject drugs (2007), World Hearlth Organization, Geneva. http://data.unaids.org/pub/PressRelease/2007/070514_hamsreduction_en.pdf http://data.unaids.org/pub/PressRelease/2007/070514_harmreduction_en.pdf. Accessed February 15, 2008
50. Wodak A., and Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Substance Use and Misuse 41 (2006) 777-813